About PharmaSGP Holding SE

Company Description

harmaSGP is a pharmaceutical company with a broad portfolio of leading, over-the-counter (OTC) drugs and other healthcare products.

Our drugs are based on natural pharmaceutical active ingredients with documented efficacy and have virtually no known side effects. With our pharmacy-exclusive products, we have trusted brands in many relevant chronic indications that are leaders in their respective categories. The herbal-medicine Baldriparan®, is the leading OTC brand in Germany for natural valerian sleep aids. With the brands RubaXX® for rheumatic pain and Restaxil® for neuralgic pain (nerve pain), we are also the market leader for systemic, chemical-free OTC pain relievers.

In addition, the products against sexual weakness, which are marketed under the brands DESEO® and NERADIN®, are the leading chemical-free products in their category in Germany.

Since the launch of the first product from the current portfolio in Germany in 2012, we have successfully exported our business.

Year founded

2019

Served area

Worldwide

Headcount

66

Headquarters

Lochhamer Schlag 21, 82166 Gräfelfing – Germany

Publications

Insider Trades

Date Trading entity / Person Association Trade type Volume Average price
05.10.22 MMI Leisure & Capital Management GmbH Close relation Buy 125,383.20 € 05.10.22
05.10.22 MMI Leisure & Capital Management GmbH Close relation Buy 26.60 € 05.10.22
05.10.22 Hillen, Ingo Board Buy 1,048.00 € 05.10.22
30.05.22 Simon-Schröter, Dr. Wolfram Other Buy 10,040.00 € 30.05.22
30.05.22 Schröter, Jasmin Close relation Buy 119,660.00 € 30.05.22
30.05.22 Wittig, Dr. Thomas Supervisory board Buy 138,953.80 € 30.05.22
25.04.22 Bloching, Prof. Dr. Micha Supervisory board Sell 171,825.00 € 25.04.22
25.04.22 MMI Leisure & Capital Management GmbH Close relation Sell 99.00 € 25.04.22
25.04.22 MMI Leisure & Capital Management GmbH Close relation Sell 197,193.60 € 25.04.22
25.04.22 FUTRUE GmbH Close relation Buy 208,180.53 € 25.04.22
07.12.21 FUTRUE GmbH Close relation Buy 550,800.00 € 07.12.21
07.12.21 MVH Beteiligungs- und Beratungs-GmbH Close relation Buy 63,750.00 € 07.12.21
02.12.21 FUTRUE GmbH Close relation Buy 5,508,000.00 € 02.12.21
02.12.21 MVH Beteiligungs- und Beratungs-GmbH Close relation Buy 612,000.00 € 02.12.21
20.10.21 Laik, Robin Board Other 2.66 € 20.10.21
19.10.21 Günther, Bernd Supervisory board Buy 89.60 € 19.10.21
18.10.21 Ceccaldi, Julie Close relation Sell 6,267.50 € 18.10.21
18.10.21 MVH Beteiligungs- und Beratungs-GmbH Close relation Buy 1,018,517.50 € 18.10.21
18.10.21 FUTRUE GmbH Close relation Buy 9,667,157.50 € 18.10.21
13.10.21 Zeitfracht GmbH & Co. KGaA Close relation Sell 61,610.00 € 13.10.21
13.10.21 Müller, Dr. Axel Supervisory board Other 4,714.50 € 13.10.21
12.10.21 FUTRUE GmbH Close relation Buy 1,743,861.20 € 12.10.21
12.10.21 Zeitfracht GmbH & Co. KGaA Close relation Sell 64,640.00 € 12.10.21
05.10.21 Horch, Johann Board Buy 7,519.48 € 05.10.21
07.07.21 MVH Beteiligungs- und Beratungs-GmbH Close relation Buy 754,425.00 € 07.07.21
07.07.21 FUTRUE GmbH Close relation Buy 6,789,825.00 € 07.07.21
01.07.21 Sultzer, Marcus Board Other 499,966.00 € 01.07.21
01.07.21 Weick, Achim Board Other 76,000.00 € 01.07.21
01.07.21 Vogel, Rony Supervisory board Other 114,000.00 € 01.07.21
28.06.21 MVH Beteiligungs- und Beratungs-GmbH Close relation Buy 716,750.00 € 28.06.21
28.06.21 FUTRUE GmbH Close relation Buy 6,450,750.00 € 28.06.21

Shareholder information

Shares outstanding

12,000,000

IPO

June 19, 2020

Designated Sponsor(s)

Joh. Berenberg, Gossler & Co. KG

Stock exchange(s)

Frankfurt Stock Exchange

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.